Alphanox to Acquire Additional Shares of U.S. Subsidiary for 5.6 Billion KRW
Alphanox announced on the 19th that it will acquire an additional 4 million shares of its U.S. implant sales subsidiary (Solco Biomedical) for approximately 5.6 billion KRW.
After the acquisition, Alphanox's ownership stake will become 100%. The scheduled date of share acquisition is the 23rd.
Hot Picks Today
"I Went for the Cheap Coffee, but Now I Feel Uneasy"... Major Coffee Franchises Cited for Violations One After Another
- "My Vicarious Satisfaction Every Night Gone: Sudden Deletion of Past Videos... Mukbang YouTubers Hit by Crackdown"
- "Yeosu City Under Fire for Official Notice Targeting Taxi Drivers over 'Malicious Rumors' about Islands Expo"
- "50 Million Won for Weekly Encounters"... Man in His 60s Sentenced for Deceiving Woman in Her 20s with Forged 1.4 Billion Won Account
- "After Spending 170,000 Won on Hanwoo, This Is What I Got": Why Webtoon Artist Kim Gyusam Decided to Give Cash Instead
The company stated that the purpose of this acquisition is to strengthen business competitiveness in the U.S. market and to improve its financial structure.
This content was produced with the assistance of AI translation services.
© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.
